David C S Huang

Solution Structure of Prosurvival Mcl-1 and Characterization of Its Binding by Proapoptotic BH3-only Ligands*

S. Richardson, Lin Chen, M. Hinds, 2005, Journal of Biological Chemistry.

The Bcl-2-regulated apoptotic pathway

S. Willis, M. Hinds, C. Day, 2003, Journal of Cell Science.

Systematic screening identifies dual PI3K and mTOR inhibition as a conserved 2 therapeutic vulnerability in osteosarcoma 3

Elizabeth Stewart, Cathryn M. Gould, Anang A Shelat, 2015 .

Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.

Lin Chen, S. Willis, A. Wei, 2005, Genes & development.

De-novo designed library of benzoylureas as inhibitors of BCL-XL: synthesis, structural and biochemical characterization.

Brian J Smith, Nathan Toovey, Jonathan B Baell, 2014, Journal of medicinal chemistry.

Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease.

Hao Xiong, Yue Cui, T. Kipps, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Bcl-2 family: roles in cell survival and oncogenesis

Suzanne Cory, S. Cory, Jerry M. Adams, 2003, Oncogene.